Endocrine and bone

Denosumab (RANKL inhibitor)

A monoclonal antibody against RANKL, the signal osteoclasts need to form and survive; a twice-yearly injection for osteoporosis, also used for bone metastases.

Mechanism of action

Molecular targets

Drugs in Denosumab (RANKL inhibitor)

Therapeutic uses

Diseases it treats

Adverse effects

Contraindications by condition

Connected topics

Written from

Educational reference. Not medical advice, diagnosis or treatment.